Literature DB >> 12884344

Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A.

André Eckardt1, Christian Kuettner.   

Abstract

BACKGROUND: Gustatory sweating is a common complication of parotid surgery. Injection of botulinum toxin A has been reported as a safe and effective treatment option for patients with Frey's syndrome. PATIENTS AND METHODS: A total of 69 patients who had undergone superficial parotidectomy because of adenoma were evaluated with respect to the incidence of Frey's syndrome and treatment interest. Minor's iodine starch test was used to detect the affected skin area. Affected skin areas were documented using a digital camera; skin areas were evaluated morphometrically. A single injection of Botox per 1 cm(2) skin field was administered to those patients interested in treatment.
RESULTS: Of 43 patients (62%) with gustatory sweating, 33 patients requested treatment. The affected skin area varied from 16 cm(2) to 81 cm(2). The individual Botox dosage ranged from 16 to 80 IU. All relevant clinical symptoms of sweating disappeared within 1 week after a single injection. Treatment was well tolerated with no side effects.
CONCLUSION: Botox A injection is a safe and effective treatment with long-lasting effects for patients with extensive gustatory sweating. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884344     DOI: 10.1002/hed.10262

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

1.  [On the diagnosis and treatment of parotid gland tumors. Results of a nationwide survey of ENT hospitals in Germany].

Authors:  S F Preuss; O Guntinas-Lichius
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

Review 2.  The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.

Authors:  D A Glaser
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

3.  [Frey's syndrome of the external auditory canal].

Authors:  J Constantinidis; G Kyriafinis; S Ereliadis; J Daniilidis
Journal:  HNO       Date:  2004-10       Impact factor: 1.284

4.  Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles.

Authors:  Shang Xie; Kan Wang; Tao Xu; Xue-Sheng Guo; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Cancer Med       Date:  2015-08-26       Impact factor: 4.452

Review 5.  Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.

Authors:  Amanda-Amrita D Lakraj; Narges Moghimi; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2013-04-23       Impact factor: 4.546

Review 6.  Botulinum Neurotoxins and Cancer-A Review of the Literature.

Authors:  Shivam Om Mittal; Bahman Jabbari
Journal:  Toxins (Basel)       Date:  2020-01-05       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.